UBS(Lux)E.F.-Biotech(USD)P a.USD
MVD-Fonds Rating | EDA |
---|---|
![]() ![]() ![]() ![]() ![]() ![]() | 74 |
ISIN: LU0069152568 | WKN: 986327
KAG: UBS Fund M. (LU)
NAV: 751,55 USD am 07.04.2021

Kennzahlen UBS(Lux)E.F.-Biotech(USD)P a.USD
1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
Performance | +1,14% | -0,58% | +25,71% | +37,15% | +56,54% | +264,05% | +651,55% |
Volatilität | +25,08% | +22,99% | +24,41% | +25,91% | +24,27% | +25,40% | +27,87% |
Sharpe Ratio | +0,61 | -0,03 | +1,08 | +0,45 | +0,41 | +0,56 | +0,33 |
Bester Monat | - | +10,70% | +14,55% | +14,95% | +14,95% | +15,66% | +41,13% |
Schl. Monat | - | -4,94% | -4,94% | -13,55% | -13,55% | -21,18% | -28,27% |
Max. Verlust | -5,67% | -14,33% | -15,52% | -25,18% | -25,72% | -40,97% | -75,23% |
Monatsperformance UBS(Lux)E.F.-Biotech(USD)P a.USD
2001 | 2000 | 1999 | 1998 | 1997 | |
Januar | -11,88% | +14,96% | +8,41% | -3,18% | +10,23% |
Februar | -5,24% | +41,13% | -7,98% | +4,75% | -1,37% |
März | -19,46% | -28,27% | -0,26% | +7,03% | -12,78% |
April | +13,22% | -8,94% | -5,91% | +2,78% | -3,24% |
Mai | +4,40% | -4,27% | +6,72% | -4,73% | +11,00% |
Juni | +2,85% | +31,61% | +7,69% | +1,03% | +0,99% |
Juli | -11,46% | -6,41% | +6,90% | -3,98% | +2,77% |
August | +0,20% | +20,88% | +8,22% | -21,12% | +3,38% |
September | -12,70% | +0,84% | -8,48% | +14,65% | +15,45% |
Oktober | +13,76% | -7,51% | +0,18% | +5,23% | -4,22% |
November | +7,79% | -15,77% | +6,52% | +7,50% | -3,25% |
Dezember | -2,24% | +6,43% | +30,26% | +7,30% | -3,86% |
Gesamt | -24,09% | +26,29% | +58,35% | +13,19% | +12,40% |